title: [Blood pressure control in hypertensive Spanish population attended in primary care setting. The PRESCAP 2010 study].
abstract: OBJECTIVE
  This study was aimed at determining the degree of blood pressure (BP) control in hypertensive patients attended in primary care (PC) settings.
  
  
  METHODS
  Cross-sectional, multicenter study. Hypertensive patients ≥18 years under antihypertensive treatment attended in Spanish PC settings were included. BP control was regarded as optimum when BP values were <140/90mmHg in general population and <130/80mmHg in patients with diabetes, chronic renal disease or cardiovascular disease. BP control was also calculated for all patients when it was <140/90mmHg.
  
  
  RESULTS
  A total of 12,961 hypertensive patients (52.0% women) with a mean age of 66.3 (±11.4) years were included. A percentage of 46.3 (95% CI: 45.4-47.1) presented good systolic BP and diastolic BP control; 61.1% (IC 95%: 60.2-61.9) of patients presented good BP control<140/90. A percentage of 63.6% was treated with combination therapy (44.1% with 2 drugs, 19.5% with 3 or more). BP control was significantly higher in evening measurements (50.4%) than in morning measurements (45.1%), and in patients who had taken the treatment before the visit (47.9%) compared with those who had not (30.5%). Factors such as not taking the medication before the visit, heavy alcohol consumption and dyslipemia were the risk factors mostly associated with a poor BP control (P<.001).
  
  
  CONCLUSIONS
  Five out of 10 hypertensive patients treated in PC settings have an optimal BP control. The degree of control of arterial hypertension has improved with respect to the PRESCAP 2006 study.
authors.affiliation: Centro de Salud Ingeniero Joaquín Benlloch, Valencia, España. jllisterric@gmail.com
authors.forename: José L
authors.initials: JL
authors.lastname: Llisterri Caro
authors.forename: Gustavo C
authors.initials: GC
authors.lastname: Rodríguez Roca
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Alonso Moreno
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Prieto Díaz
authors.forename: José R
authors.initials: JR
authors.lastname: Banegas Banegas
authors.forename: Diego
authors.initials: D
authors.lastname: Gonzalez-Segura Alsina
authors.forename: Salvador
authors.initials: S
authors.lastname: Lou Arnal
authors.forename: Juan A
authors.initials: JA
authors.lastname: Divisón Garrote
authors.forename: Pere
authors.initials: P
authors.lastname: Beato Fernández
authors.forename: Vivencio
authors.initials: V
authors.lastname: Barrios Alonso
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000428:Alcohol Drinking / Q000453:epidemiology; D000886:Anthropometry; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000453:epidemiology; D002940:Circadian Rhythm; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology; D050171:Dyslipidemias / Q000453:epidemiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D007674:Kidney Diseases / Q000453:epidemiology; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology; D011320:Primary Health Care / Q000706:statistics & numerical data*; D012907:Smoking / Q000453:epidemiology; D013030:Spain / Q000453:epidemiology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents